Noah Clauser

Insider Reports History

Location
Boston, MA
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Noah Clauser
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Noah Clauser:

Company Role Class Num Shares Value Price $ Report Date Ownership
Astria Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 262,500 21 Mar 2025 Direct

Insider Reports Filed by Noah Clauser

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATXS Astria Therapeutics, Inc. 21 Mar 2025 1 $0 4 Chief Financial Officer 25 Mar 2025, 16:05
ATXS Astria Therapeutics, Inc. 08 Feb 2024 1 $0 4 Chief Financial Officer 12 Feb 2024, 16:05
ATXS Astria Therapeutics, Inc. 02 Jun 2023 1 $0 4 Chief Financial Officer 06 Jun 2023, 08:03
ATXS Astria Therapeutics, Inc. 01 Mar 2022 1 $0 4 Chief Financial Officer 03 Mar 2022, 18:20
ATXS CATABASIS PHARMACEUTICALS INC 02 Jun 2021 1 $0 4 Chief Financial Officer 02 Jun 2021, 19:17